Condition
Opioid Craving
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (2)
Trial Status
Recruiting3
Enrolling By Invitation1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05511909Phase 2Recruiting
Evaluating Buspirone to Treat Opioid Withdrawal
NCT07361731Not ApplicableEnrolling By Invitation
Evaluating the Feasibility, Acceptability, and Preliminary Outcomes of Heart Rate Variability Biofeedback for Individuals With Opioid Use Disorder.
NCT05109429Not ApplicableRecruitingPrimary
Developing a Clinical Outcome Assessment for Opioid Craving
NCT05027919Phase 2Recruiting
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
NCT04238754Phase 1Completed
Oral Cannabidiol for Opioid Withdrawal
Showing all 5 trials